Jeffrey B. Mirviss Boston Scientific Corp (BSX) insider trading activity

Jeffrey B. Mirviss is EVP&Pres, Periph Intervent of BOSTON SCIENTIFIC CORP. Currently has a direct ownership of 28,022 shares of BSX, which is worth approximately $2.5 Million. The most recent transaction as insider was on Dec 03, 2022, when has been sold 649 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 28K

0% 3M change

50.48% 12M change

Total Value Held $2.5 Million

Jeffrey B. Mirviss Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Dec 03 2022	BUY Exercise of conversion of derivative security	-	649 Added 0.58%	111,288 Common Stock
Nov 01 2022	SELL Bona fide gift	-	230 Reduced 0.21%	110,639 Common Stock
May 16 2022	SELL Bona fide gift	-	26 Reduced 0.02%	110,290 Common Stock
Apr 20 2022	SELL Open market or private sale	$448,492 $46.5 p/Share	9,645 Reduced 8.04%	110,316 Common Stock
Apr 19 2022	SELL Open market or private sale	$500,000 $45.5 p/Share	10,989 Reduced 8.39%	119,961 Common Stock
Mar 22 2022	SELL Open market or private sale	$500,002 $44.5 p/Share	11,236 Reduced 7.9%	130,950 Common Stock
Feb 28 2022	SELL Payment of exercise price or tax liability	$27,562 $44.17 p/Share	624 Reduced 0.44%	142,186 Common Stock
Feb 28 2022	BUY Exercise of conversion of derivative security	-	2,037 Added 1.41%	142,810 Common Stock
Feb 21 2022	SELL Payment of exercise price or tax liability	$36,550 $42.55 p/Share	859 Reduced 0.61%	140,773 Common Stock
Feb 21 2022	BUY Exercise of conversion of derivative security	-	2,804 Added 1.94%	141,632 Common Stock
Feb 18 2022	SELL Payment of exercise price or tax liability	$36,678 $42.55 p/Share	862 Reduced 0.62%	138,828 Common Stock
Feb 18 2022	BUY Exercise of conversion of derivative security	-	2,816 Added 1.98%	139,690 Common Stock
Feb 17 2022	SELL Payment of exercise price or tax liability	$43,687 $42.83 p/Share	1,020 Reduced 0.74%	136,874 Common Stock
Feb 17 2022	BUY Exercise of conversion of derivative security	-	3,333 Added 2.36%	137,894 Common Stock
Feb 15 2022	SELL Payment of exercise price or tax liability	$27,374 $44.01 p/Share	622 Reduced 0.46%	134,561 Common Stock
Feb 15 2022	BUY Exercise of conversion of derivative security	-	2,030 Added 1.48%	135,183 Common Stock
Jan 04 2022	SELL Open market or private sale	$297,814 $43.54 p/Share	6,840 Reduced 4.89%	133,153 Common Stock
Jan 01 2022	SELL Payment of exercise price or tax liability	$138,697 $42.48 p/Share	3,265 Reduced 2.28%	139,993 Common Stock
Jan 01 2022	BUY Exercise of conversion of derivative security	-	10,105 Added 6.59%	143,258 Common Stock
Dec 03 2021	SELL Payment of exercise price or tax liability	$11,680 $39.46 p/Share	296 Reduced 0.22%	133,153 Common Stock
Dec 03 2021	BUY Exercise of conversion of derivative security	-	649 Added 0.48%	133,449 Common Stock
Aug 31 2021	SELL Bona fide gift	-	135 Reduced 0.1%	132,800 Common Stock
Aug 30 2021	SELL Bona fide gift	-	183 Reduced 0.14%	132,935 Common Stock
Jul 27 2021	SELL Open market or private sale	$305,145 $45.22 p/Share	6,748 Reduced 4.82%	133,118 Common Stock
Apr 28 2021	SELL Open market or private sale	$2,130,347 $43.98 p/Share	48,439 Reduced 25.82%	139,158 Common Stock

JBM

Jeffrey B. Mirviss

EVP&Pres, Periph Intervent

Marlborough, MA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells BSX shares.

Notify only if

Value

Insider Trading

Get notified when an Boston Scientific Corp insider buys or sells BSX shares.

Notify only if

Operation

Value

Type

News

Receive news related to BOSTON SCIENTIFIC CORP

Track Activities on BSX

Account